These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 25042563)

  • 1. Hippo-YAP signaling pathway: A new paradigm for cancer therapy.
    Ma Y; Yang Y; Wang F; Wei Q; Qin H
    Int J Cancer; 2015 Nov; 137(10):2275-86. PubMed ID: 25042563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
    Zhao B; Lei QY; Guan KL
    Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research advances in the role of the Hippo-YAP/TAZ signaling pathway in primary liver cancer].
    Guo LW; Shao GL
    Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):878-880. PubMed ID: 29325286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.
    Kodaka M; Hata Y
    Cell Mol Life Sci; 2015 Jan; 72(2):285-306. PubMed ID: 25266986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment.
    Santucci M; Vignudelli T; Ferrari S; Mor M; Scalvini L; Bolognesi ML; Uliassi E; Costi MP
    J Med Chem; 2015 Jun; 58(12):4857-73. PubMed ID: 25719868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the ambivalent role of YAP/TAZ in human cancers.
    Luo J; Deng L; Zou H; Guo Y; Tong T; Huang M; Ling G; Li P
    J Exp Clin Cancer Res; 2023 May; 42(1):130. PubMed ID: 37211598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway.
    Ehmer U; Sage J
    Mol Cancer Res; 2016 Feb; 14(2):127-40. PubMed ID: 26432795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippo signaling dysfunction induces cancer cell addiction to YAP.
    Han H; Yang B; Nakaoka HJ; Yang J; Zhao Y; Le Nguyen K; Bishara AT; Mandalia TK; Wang W
    Oncogene; 2018 Dec; 37(50):6414-6424. PubMed ID: 30068939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting YAP and Hippo signaling pathway in liver cancer.
    Liu AM; Xu MZ; Chen J; Poon RT; Luk JM
    Expert Opin Ther Targets; 2010 Aug; 14(8):855-68. PubMed ID: 20545481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.
    Lin C; Yao E; Chuang PT
    Dev Biol; 2015 Jul; 403(1):101-13. PubMed ID: 25912685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
    Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X
    Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two faces of Hippo: activate or suppress the Hippo pathway in cancer.
    Cao J; Huang W
    Anticancer Drugs; 2017 Nov; 28(10):1079-1085. PubMed ID: 28926422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies.
    Kim MH; Kim J
    Cell Mol Life Sci; 2017 Apr; 74(8):1457-1474. PubMed ID: 27826640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade.
    Budel SJ; Penning MM; Penning LC
    Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hippo pathway in normal development and cancer.
    Maugeri-Saccà M; De Maria R
    Pharmacol Ther; 2018 Jun; 186():60-72. PubMed ID: 29305295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo Signaling Pathway in Pancreatic Cancer.
    Ansari D; Ohlsson H; Althini C; Bauden M; Zhou Q; Hu D; Andersson R
    Anticancer Res; 2019 Jul; 39(7):3317-3321. PubMed ID: 31262852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
    Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
    Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
    Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
    J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.